Antibodies to von Willebrand factor in von Willebrand disease-Reference-Cited by-同舟云学术

Antibodies to von Willebrand factor in von Willebrand disease

Published:1995 Issue: Volume: Page:87-92
ISSN:0065-2598
Container-title:Advances in Experimental Medicine and Biology
language:
Short-container-title:

Author:

Mannucci P. M.,Federici A. B.

Publisher

Springer US

Link

http://link.springer.com/content/pdf/10.1007/978-1-4613-0331-2_7

Reference23 articles.

1. Bloom AL, Peake IR, Furlong RA and Davies BL. High potency factor VIII concentrate: more effective than cryoprecipitate in a patient with von Willebrand’s disease and inhibitor. Thromb Res 16: 847 (1979).

2. Egberg N and Blomback M. On the characterization of acquired inhibitors to ristocetin-induced platelet aggregation found in patients with von Willebrand’s disease. Thromb Res 9: 527 (1976).

3. Ginsburg D and Sadler JE. von Willebrand disease: a database of point mutations, insertions and deletions. Thromb Haemostas 69: 177 (1993).

4. Hanna WT. Replacement therapy for surgery in type III von Willebrand patient with inhibitors to factor VIII procoagulant. Thromb Haemostas 62: 224 (1989) (abstract).

5. Lenk H, Weissbach G and Donula M. Ein Hemmkorper bei von Willebrand Jurgens- Syndrome and seine Wirkung aur die Eigenschaften des Factor VIII molekuls. Folia Haematol 105: 826 (1978).

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emicizumab in Type 3 von Willebrand Disease: Report of a Case with an Alloantibody and Literature Review;Seminars in Thrombosis and Hemostasis;2024-06-27

2. von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPS;Journal of Thrombosis and Haemostasis;2023-04

3. Combination therapy with von Willebrand factor concentrate plus recombinant factor VIII during cesarean section in a patient with type 3 von Willebrand disease and a low inhibitor titer: a case report;International Journal of Hematology;2022-05-09

4. Rare Occurrence of Inhibitors in Von Willebrand Disease: A Case Report;Frontiers in Medicine;2022-01-11

5. Efficacy of emicizumab in von Willebrand disease (VWD) patients with and without alloantibodies to von Willebrand factor (VWF): Report of two cases and review of literature;Haemophilia;2022-01-10